Ibex Medical Analytics vs Proscia Concentriq
Ibex Medical Analytics and Proscia Concentriq both compete in pathology, but answer different questions. Ibex Medical Analytics is our pick for deployed globally: Most-deployed AI pathology platform globally. Proscia Concentriq earns the pharma R&D labs slot: Used by 16/20 top pharma. $130M total funding. The right choice depends on whether your priority is deployed globally or pharma r&d labs.
- Pathology
- 02
- October 20, 2026
Ibex Medical Analytics
by Ibex
AI pathology software for prostate, breast and gastric cancer. One US FDA 510(k) clearance, for prostate.
- No public price. Sold to laboratories and health systems on enterprise contracts.
- FDA 510(k)
Proscia Concentriq
by Proscia
Concentriq pathology platform for clinical labs and biopharma: image management, case review and AI apps, with FDA-cleared AP-Dx for primary diagnosis.
- No public price. Demo request only.
- FDA 510(k) / SOC 2 Type II (vendor announcement, 2025-12-03) / ISO 27001 (vendor-stated, 2023)
How Ibex Medical Analytics and Proscia Concentriq compare
Pricing, compliance, and integrations sourced from vendor documentation. Verified October 20, 2026.
| Spec | Ibex Medical Analytics | Proscia Concentriq |
|---|---|---|
| Pricing | No public price. Sold to laboratories and health systems on enterprise contracts. | No public price. Demo request only. |
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | — | — |
| HQ | IL | — |
| Best for | Best deployed globally | Best for pharma R&D labs |
Scroll horizontally to see both columns.
When to pick each one
Best deployed globally
Most-deployed AI pathology platform globally.
- Israeli-origin
- Prostate, breast, colon focus
- Broad EU + US deployments
Best for pharma R&D labs
Used by 16/20 top pharma. $130M total funding.
- IMS platform + AI marketplace
- Strongest pharma R&D footprint
Other head-to-heads worth reading
Open the full pathology comparison
Digital pathology workflows with FDA-cleared cancer detection (prostate, breast, colon), IHC scoring (HER2, Ki67), and AI-powered image management. Tempus, PathAI, Proscia dominate.